April 18 2018 | 0 Comments | 122 reads Average Rating: 3
Poll Results: Ready to Embrace Outcomes-Based Contracts?
During a recent webinar entitled, “Outcomes-Based Contracts Between Pharma and Payers: Preparing for the Future, Now!”, John Pagliuca, Vice President, Life Sciences at SCIO Health Analytics, examined the ins-and-outs associated with outcomes-based contracts between payer organizations and pharmaceutical companies – and explained how these contracts could benefit all involved.
Through real-time online polls delivered during the webinar, participants provided insight into how far along their organizations are with the actual use of outcomes-based contracts.
While hyphenate outcomes-based contracts offer a means for pharma manufacturers to demonstrate the value of their products, payers and pharma companies are just starting to pursue such collaborative agreements. Indeed, most organizations are just learning about these contracts – while some are dipping their toes in the water.
The value of outcomes-based contracts is becoming more apparent from a conceptual perspective. However, when the rubber meets the road, organizations are struggling to agree upon the exact metrics that need to be measured and monitored under these agreements.
These poll results offer insights into how healthcare organizations are far along with the actual use of outcomes-based contracts. How is your organization handling outcomes-based contracts?